LFST vs. PINC, PRVA, USPH, DNLI, NEOG, ARWR, TNDM, IMCR, TGTX, and ENOV
Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Premier (PINC), Privia Health Group (PRVA), U.S. Physical Therapy (USPH), Denali Therapeutics (DNLI), Neogen (NEOG), Arrowhead Pharmaceuticals (ARWR), Tandem Diabetes Care (TNDM), Immunocore (IMCR), TG Therapeutics (TGTX), and Enovis (ENOV). These companies are all part of the "medical" sector.
LifeStance Health Group (NASDAQ:LFST) and Premier (NASDAQ:PINC) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, community ranking, earnings and media sentiment.
LifeStance Health Group has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Comparatively, Premier has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500.
Premier has a net margin of 6.01% compared to LifeStance Health Group's net margin of -15.69%. Premier's return on equity of 11.71% beat LifeStance Health Group's return on equity.
85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 6.6% of LifeStance Health Group shares are held by insiders. Comparatively, 0.9% of Premier shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Premier received 602 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 69.07% of users gave Premier an outperform vote while only 26.32% of users gave LifeStance Health Group an outperform vote.
Premier has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks.
In the previous week, LifeStance Health Group had 1 more articles in the media than Premier. MarketBeat recorded 8 mentions for LifeStance Health Group and 7 mentions for Premier. LifeStance Health Group's average media sentiment score of 0.50 beat Premier's score of 0.23 indicating that LifeStance Health Group is being referred to more favorably in the media.
LifeStance Health Group currently has a consensus target price of $8.80, suggesting a potential upside of 19.08%. Premier has a consensus target price of $23.50, suggesting a potential upside of 19.53%. Given Premier's higher possible upside, analysts plainly believe Premier is more favorable than LifeStance Health Group.
Summary
Premier beats LifeStance Health Group on 10 of the 18 factors compared between the two stocks.
Get LifeStance Health Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LifeStance Health Group Competitors List
Related Companies and Tools
